AI assistant
Sending…
LOEWS CORP — Director's Dealing 2013
Oct 31, 2013
30284_dirs_2013-10-31_fc7dde56-4b9d-42bf-b226-9eecd34649d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LOEWS CORP (L)
CIK: 0000060086
Period of Report: 2013-10-29
Reporting Person: GARSON GARY W (Sr. Vice Pres., GC & Sec.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-29 | Common Stock | M | 11150 | $23.68 | Acquired | 11150 | Direct |
| 2013-10-29 | Common Stock | M | 11250 | $24.32 | Acquired | 22400 | Direct |
| 2013-10-29 | Common Stock | S | 22400 | $48.87 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-10-29 | Stock Option | $23.68 | M | 11150 | Disposed | 2015-01-20 | Common Stock (11150) | Direct |
| 2013-10-29 | Stock Option | $24.32 | M | 11250 | Disposed | 2015-01-20 | Common Stock (11250) | Direct |
Footnotes
F1: Represents the weighted average price of multiple transactions with a range of prices between $48.71 and $48.98. The Reporting Person upon request by the Commission Staff, the Issuer or a security holder of the Issuer undertakes to provide further information regarding the number of securities at each separate price sold.
F2: The stock option became exercisable in four equal annual installments beginning on January 20, 2006.
F3: The Reporting Person received the Derivative Security pursuant to a stock option grant at no cost.
More from LOEWS CORP
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Feb 18
Director's Dealing
2026
Feb 18